Home › Kanser sa Suso › Wisconsin › Milwaukee
Pag-aaral pangklinika para sa Kanser sa Suso sa Milwaukee, WI
Isang pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Milwaukee. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
The Vanguard Study: Testing a New Way to Screen for Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Zablocki Veterans Administration Medical Center, Milwaukee
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- at 9 pa
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Nagre-recruitPhase 1
- Research Site, Milwaukee
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Nagre-recruitPhase 3
- Clinical Trial Site, Milwaukee
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Nagre-recruitPhase 3
- Medical College of Wisconsin, Milwaukee
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Nagre-recruitPhase 1/2
- Froedtert & MCW Cancer Center, Milwaukee
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Nagre-recruitPhase 3
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
Nagre-recruitPhase 2
- Medical College of Wisconsin, Milwaukee
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Nagre-recruitPhase 3
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Medical College of Wisconsin, Milwaukee
- at 8 pa
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Nagre-recruitPhase 1
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
Nagre-recruit
- Froedtert Hospital, Milwaukee
Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer
Nagre-recruit
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
E-Mindfulness Approaches for Living After Breast Cancer
Nagre-recruitPhase 3
- UW Cancer Center at ProHealth Care, Waukesha · 17 mi ang layo
- ProHealth D N Greenwald Center, Mukwonago · 25 mi ang layo
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Nagre-recruitPhase 3
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Medical College of Wisconsin, Milwaukee
- at 9 pa
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Nagre-recruitObservasyonal na pag-aaral
- Aurora Cancer Care-Milwaukee, Milwaukee
- Ascension Columbia Saint Mary's Hospital - Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- at 10 pa
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Nagre-recruitObservasyonal na pag-aaral
- Medical College of Wisconsin, Milwaukee
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
Nagre-recruitPhase 1
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Nagre-recruitObservasyonal na pag-aaral
- Aurora Cancer Care - Wauwatosa, Wauwatosa · 5 mi ang layo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Milwaukee
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
Nagre-recruitPhase 2
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Individuals on Hormone Therapy Breast Cancer Screening Pilot
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Medical College of Wisconsin, Milwaukee
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Nagre-recruitObservasyonal na pag-aaral
- Columbia St. Mary's, Milwaukee
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
Nagre-recruit
- Medical College of Wisconsin, Milwaukee
Pag-aaral para sa Kanser sa Suso sa ibang lungsod
- New York City, NY136 pag-aaral
- Houston, TX126 pag-aaral
- Boston, MA112 pag-aaral
- Nashville, TN81 pag-aaral
- Los Angeles, CA73 pag-aaral
- Edison, NJ68 pag-aaral
- St. Louis, MO64 pag-aaral
- Queens, NY64 pag-aaral
- Durham, NC64 pag-aaral
- Chicago, IL59 pag-aaral
- Philadelphia, PA56 pag-aaral
- Dallas, TX55 pag-aaral
Iba pang pag-aaral sa Milwaukee
- Kanser (lahat ng uri)22 pag-aaral
- Non-Small Cell Lung Cancer22 pag-aaral
- Multiple Myeloma21 pag-aaral
- Kanser sa Baga21 pag-aaral
- Kanser sa Prostate20 pag-aaral
- Follicular Lymphoma19 pag-aaral
- Non-Hodgkin Lymphoma18 pag-aaral
- Kanser sa Pancreas18 pag-aaral
- Acute Myeloid Leukemia17 pag-aaral
- Kanser sa Ovary17 pag-aaral
- Diffuse Large B-Cell Lymphoma16 pag-aaral
- Burkitt Lymphoma16 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.